826 results on '"Bertoletti, Antonio"'
Search Results
152. Early induction of SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
153. HBV as a target for CAR or TCR-T cell therapy
154. T cell receptor-engineered mucosal-associated invariant T cells with antiviral cytotoxic potential against hepatitis virus replicating hepatoma cells
155. Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection
156. Safety and efficacy of up to 76 weeks 10 mg (high dose) bulevirtide monotherapy in compensated cirrhotics with delta hepatitis
157. A Dynamic Immune Response Shapes COVID-19 Progression
158. Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals
159. Personalized T-cell therapy in liver transplanted patients with hepatitis B virus related hepatocellular carcinoma
160. Early treatment of chronic hepatitis B in children: Everything to play for?
161. Challenges of CAR- and TCR-T cell–based therapy for chronic infections
162. IFN-α Suppresses Myeloid Cytokine Production, Impairing IL-12 Production and the Ability to Support T-Cell Proliferation
163. T cells: an essential but neglected component against COVID-19
164. Hepatitis Delta Virus Infection Increases the Efficacy of HBV-Specific T Cell-Based Therapies
165. HBV antigens quantity: duration and effect on functional cure.
166. The Effects of Pathogens on the Immune System: Viral Hepatitis
167. Therapeutic vaccination and novel strategies to treat chronic HBV infection
168. Viral hepatitis and serotonin: altering cytotoxic T-lymphocyte function in the liver
169. Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospective
170. Sustained and Focused Hepatitis B Virus Nucleocapsid–Specific T-Cell Immunity in Liver Transplant Recipients Compared To Individuals With Chronic and Self-Limited Hepatitis B Virus Infection
171. Immune response and tolerance during chronic hepatitis B virus infection
172. The influence of T cell cross-reactivity on HCV-peptide specific human T cell response
173. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
174. 31 - Virology and Pathogenesis of Hepatitis B
175. Control or persistence of hepatitis B virus: The critical role of initial host-virus interactions
176. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
177. Translation of immunological knowledge into better treatments of chronic hepatitis B
178. The role of virus-specific CD8 cells in liver damage and viral control during HBV infection
179. The Role of Virus-specific CD8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection
180. HEPATITIS B VIRUS (HBV)-SPECIFIC CD8 CELLS WITH DIVERSE T CELL RECEPTORS DISPLAY LIMITED FLEXIBILITY IN THE RECOGNITION OF A SINGLE HBV CORE EPITOPE.
181. Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients
182. Fine‐Tuning TLR‐7‐Based Therapy for Functional HBV Cure
183. Update of the statements on biology and clinical impact of occult hepatitis B virus infection
184. PS-141-CyTOF-based immune monitoring of HBV-HCC patients receiving autologous anti-tumour T-cell therapy
185. PS-079-HDV co-infection modifies the immunoproteasome profile of HBV infected hepatocytes leading to increased CD8 T-cell recognition: Implication for immunotherapy
186. Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
187. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection
188. Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection
189. HBV antiviral immunity: not all CD8 T cells are born equal
190. Lamivudine Treatment Can Restore T Cell Responsiveness in Chronic Hepatitis B
191. Long-lasting Memory T Cell Responses following Self-limited Acute Hepatitis B
192. Microfluidic models for adoptive cell-mediated cancer immunotherapies
193. Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model
194. Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection
195. Corrigendum: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes
196. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?
197. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus
198. Immunotherapy for Chronic Hepatitis B Virus Infection
199. Corrigendum: Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model
200. Nonstimulatory peptide–MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.